Zin R, Jalaludin M, Zain F, Hong J, Kamil N, Mokhtar A
Diabetol Metab Syndr. 2024; 16(1):268.
PMID: 39523406
PMC: 11552173.
DOI: 10.1186/s13098-024-01493-8.
Valizadeh M, Ahmadi A, Abbaspour F, Valizadeh A, Syed Hasani A, Moteshakereh S
Eat Weight Disord. 2024; 29(1):69.
PMID: 39487860
PMC: 11531429.
DOI: 10.1007/s40519-024-01697-x.
Qiu Y, Fan S, Liu J, He X, Zhu T, Yan L
Clin Cardiol. 2024; 47(10):e70020.
PMID: 39402891
PMC: 11473791.
DOI: 10.1002/clc.70020.
Zhao L, Cui M, Yang S, Zhou H, Li M
J Inflamm Res. 2024; 17:6905-6916.
PMID: 39372594
PMC: 11451455.
DOI: 10.2147/JIR.S474201.
Wang J, Apizi A, Qiu H, Tao N, An H
Front Endocrinol (Lausanne). 2024; 15:1442740.
PMID: 39165513
PMC: 11333236.
DOI: 10.3389/fendo.2024.1442740.
Changes in metabolic overweight phenotypes over time and risk of nephrolithiasis: a cohort study.
Cheng Y, Zheng H, Yin H, Yin D, Wang H, Wang Y
BMC Public Health. 2024; 24(1):1898.
PMID: 39014388
PMC: 11251252.
DOI: 10.1186/s12889-024-19229-8.
Advantages and Limitations of the Body Mass Index (BMI) to Assess Adult Obesity.
Wu Y, Li D, Vermund S
Int J Environ Res Public Health. 2024; 21(6).
PMID: 38929003
PMC: 11204233.
DOI: 10.3390/ijerph21060757.
Transition in metabolic health phenotypes across general adiposity categories and association with the risk of depression: a prospective analysis.
Zhu Y, Yin Y, Huang F, Liu Y, Xia Y, Zhang M
Eur Psychiatry. 2024; 67(1):e26.
PMID: 38418418
PMC: 10988159.
DOI: 10.1192/j.eurpsy.2024.20.
The Semmelweis Study: a longitudinal occupational cohort study within the framework of the Semmelweis Caring University Model Program for supporting healthy aging.
Ungvari Z, Tabak A, Adany R, Purebl G, Kaposvari C, Fazekas-Pongor V
Geroscience. 2023; 46(1):191-218.
PMID: 38060158
PMC: 10828351.
DOI: 10.1007/s11357-023-01018-7.
Metabolically Healthy Obesity is not a Myth.
Farabi S, Smith G, Yoshino J, Klein S
JCEM Case Rep. 2023; 1(2):luad015.
PMID: 37908482
PMC: 10580468.
DOI: 10.1210/jcemcr/luad015.
Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment.
Ding Y, Deng Q, Yang M, Niu H, Wang Z, Xia S
Diabetes Metab Syndr Obes. 2023; 16:3303-3329.
PMID: 37905232
PMC: 10613411.
DOI: 10.2147/DMSO.S431251.
Metabolic phenotyping in people living with obesity: Implications for dietary prevention.
Blaak E, Goossens G
Rev Endocr Metab Disord. 2023; 24(5):825-838.
PMID: 37581871
PMC: 10492670.
DOI: 10.1007/s11154-023-09830-4.
Cardiovascular risk of metabolically healthy obesity in two european populations: Prevention potential from a metabolomic study.
Wei D, Gonzalez-Marrachelli V, Melgarejo J, Liao C, Hu A, Janssens S
Cardiovasc Diabetol. 2023; 22(1):82.
PMID: 37029406
PMC: 10082537.
DOI: 10.1186/s12933-023-01815-6.
Metabolic health and adiposity transitions and risks of type 2 diabetes and cardiovascular diseases: a systematic review and meta-analysis.
Zhang X, Zhu J, Kim J, Sumerlin T, Feng Q, Yu J
Diabetol Metab Syndr. 2023; 15(1):60.
PMID: 36973730
PMC: 10045173.
DOI: 10.1186/s13098-023-01025-w.
Prediction of Metabolic Disorders Using NMR-Based Metabolomics: The Shanghai Changfeng Study.
Wu Q, Huang Q, Zeng H, Ma S, Lin H, Xia M
Phenomics. 2023; 1(4):186-198.
PMID: 36939780
PMC: 9590528.
DOI: 10.1007/s43657-021-00021-2.
Risk of subclinical atherosclerosis across metabolic transition in individuals with or without fatty liver disease: a prospective cohort study.
Xin Z, Huang J, Cao Q, Wang J, He R, Hou T
Nutr Metab (Lond). 2023; 20(1):15.
PMID: 36899397
PMC: 10007748.
DOI: 10.1186/s12986-023-00734-3.
Transition patterns of metabolism-weight phenotypes over time: A longitudinal study using the multistate Markov model in China.
Zhang H, Tang X, Hu D, Li G, Song G
Front Public Health. 2023; 10:1026751.
PMID: 36589938
PMC: 9799718.
DOI: 10.3389/fpubh.2022.1026751.
Implications of metabolic health status and obesity on the risk of kidney cancer: A nationwide population-based cohort study.
Cho Y, Kim H, Park J, Lee W, Kim Y, Jung C
Front Endocrinol (Lausanne). 2022; 13:976056.
PMID: 36339433
PMC: 9631209.
DOI: 10.3389/fendo.2022.976056.
Pathogenesis, Murine Models, and Clinical Implications of Metabolically Healthy Obesity.
Cho Y, La Lee Y, Jung C
Int J Mol Sci. 2022; 23(17).
PMID: 36077011
PMC: 9455655.
DOI: 10.3390/ijms23179614.
Association between non-alcoholic fatty liver disease and metabolically healthy deterioration across different body shape phenotypes at baseline and change patterns.
Lei L, Changfa W, Jiangang W, Zhiheng C, Ting Y, Xiaoling Z
Sci Rep. 2022; 12(1):14786.
PMID: 36042236
PMC: 9427771.
DOI: 10.1038/s41598-022-18988-x.
